These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28717350)

  • 1. Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted
    McMahon KM; Plebanek MP; Thaxton CS
    Adv Funct Mater; 2016 Nov; 26(43):7824-7835. PubMed ID: 28717350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rerouting Native HDL to Predetermined Receptors for Improved Tumor-Targeted Gene Silencing Therapy.
    Ding Y; Han Y; Wang R; Wang Y; Chi C; Zhao Z; Zhang H; Wang W; Yin L; Zhou J
    ACS Appl Mater Interfaces; 2017 Sep; 9(36):30488-30501. PubMed ID: 28828863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins for the systemic delivery of short interfering RNA.
    McMahon KM; Thaxton CS
    Expert Opin Drug Deliv; 2014 Feb; 11(2):231-47. PubMed ID: 24313310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery.
    Damiano MG; Mutharasan RK; Tripathy S; McMahon KM; Thaxton CS
    Adv Drug Deliv Rev; 2013 May; 65(5):649-62. PubMed ID: 22921597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Particulates Inspired Specific-Targeted Codelivery of siRNA and Paclitaxel for Collaborative Antitumor Therapy.
    Wang R; Zhao Z; Han Y; Hu S; Opoku-Damoah Y; Zhou J; Yin L; Ding Y
    Mol Pharm; 2017 Sep; 14(9):2999-3012. PubMed ID: 28753317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein.
    Catanese MT; Graziani R; von Hahn T; Moreau M; Huby T; Paonessa G; Santini C; Luzzago A; Rice CM; Cortese R; Vitelli A; Nicosia A
    J Virol; 2007 Aug; 81(15):8063-71. PubMed ID: 17507483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles.
    Lin Q; Chen J; Jin H; Ng KK; Yang M; Cao W; Ding L; Zhang Z; Zheng G
    Nanomedicine (Lond); 2012 Dec; 7(12):1813-25. PubMed ID: 22830501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Delivery of Folate-PEG siRNA Lipopolyplexes with Enhanced Intracellular Stability for In Vivo Gene Silencing in Leukemia.
    Lee DJ; Kessel E; Lehto T; Liu X; Yoshinaga N; Padari K; Chen YC; Kempter S; Uchida S; Rädler JO; Pooga M; Sheu MT; Kataoka K; Wagner E
    Bioconjug Chem; 2017 Sep; 28(9):2393-2409. PubMed ID: 28772071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
    Lee SH; Chung BH; Park TG; Nam YS; Mok H
    Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scavenger receptor B1 (SR-B1) substrates inhibit the selective uptake of high-density-lipoprotein cholesteryl esters by rat parenchymal liver cells.
    Fluiter K; van Berkel TJ
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):515-9. PubMed ID: 9291126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1.
    Ljunggren SA; Levels JH; Hovingh K; Holleboom AG; Vergeer M; Argyri L; Gkolfinopoulou C; Chroni A; Sierts JA; Kastelein JJ; Kuivenhoven JA; Lindahl M; Karlsson H
    Biochim Biophys Acta; 2015 Dec; 1851(12):1587-95. PubMed ID: 26454245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia.
    McMahon KM; Scielzo C; Angeloni NL; Deiss-Yehiely E; Scarfo L; Ranghetti P; Ma S; Kaplan J; Barbaglio F; Gordon LI; Giles FJ; Thaxton CS; Ghia P
    Oncotarget; 2017 Feb; 8(7):11219-11227. PubMed ID: 28061439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo.
    Lee JB; Zhang K; Tam YY; Quick J; Tam YK; Lin PJ; Chen S; Liu Y; Nair JK; Zlatev I; Rajeev KG; Manoharan M; Rennie PS; Cullis PR
    Mol Ther Nucleic Acids; 2016; 5(8):e348. PubMed ID: 28131285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
    Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
    J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.